148 related articles for article (PubMed ID: 22798523)
1. Hemodynamic, hormonal, and renal effects of (pro)renin receptor blockade in experimental heart failure.
Rademaker MT; Yandle TG; Ellmers LJ; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2012 Sep; 5(5):645-52. PubMed ID: 22798523
[TBL] [Abstract][Full Text] [Related]
2. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.
Rademaker MT; Charles CJ; Espiner EA; Fisher S; Frampton CM; Kirkpatrick CM; Lainchbury JG; Nicholls MG; Richards AM; Vale WW
J Am Coll Cardiol; 2002 Oct; 40(8):1495-505. PubMed ID: 12392842
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic, Hormonal, and Renal Actions of Phosphodiesterase-9 Inhibition in Experimental HeartĀ Failure.
Scott NJA; Rademaker MT; Charles CJ; Espiner EA; Richards AM
J Am Coll Cardiol; 2019 Aug; 74(7):889-901. PubMed ID: 31416533
[TBL] [Abstract][Full Text] [Related]
4. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
5. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure.
Rademaker MT; Cameron VA; Charles CJ; Richards AM
Circulation; 2005 Dec; 112(23):3624-32. PubMed ID: 16330704
[TBL] [Abstract][Full Text] [Related]
6. Prolonged urocortin 2 administration in experimental heart failure: sustained hemodynamic, endocrine, and renal effects.
Rademaker MT; Charles CJ; Ellmers LJ; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2011 Jun; 57(6):1136-44. PubMed ID: 21536988
[TBL] [Abstract][Full Text] [Related]
7. Long-term adrenomedullin administration in experimental heart failure.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM
Hypertension; 2002 Nov; 40(5):667-72. PubMed ID: 12411460
[TBL] [Abstract][Full Text] [Related]
8. Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats.
te Riet L; van den Heuvel M; Peutz-Kootstra CJ; van Esch JH; van Veghel R; Garrelds IM; Musterd-Bhaggoe U; Bouhuizen AM; Leijten FP; Danser AH; Batenburg WW
Am J Physiol Renal Physiol; 2014 May; 306(10):F1179-89. PubMed ID: 24694588
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic, hormonal, and renal actions of adrenomedullin 2 in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2008 Jul; 1(2):134-42. PubMed ID: 19808282
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic, endocrine and renal actions of adrenomedullin 5 in an ovine model of heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2012 May; 122(9):429-37. PubMed ID: 22087608
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
[TBL] [Abstract][Full Text] [Related]
12. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure.
Rademaker MT; Charles CJ; Lewis LK; Yandle TG; Cooper GJ; Coy DH; Richards AM; Nicholls MG
Circulation; 1997 Sep; 96(6):1983-90. PubMed ID: 9323090
[TBL] [Abstract][Full Text] [Related]
13. TRV120027, a novel Ī²-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure.
Boerrigter G; Soergel DG; Violin JD; Lark MW; Burnett JC
Circ Heart Fail; 2012 Sep; 5(5):627-34. PubMed ID: 22891045
[TBL] [Abstract][Full Text] [Related]
14. Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure.
Troughton RW; Rademaker MT; Powell JD; Yandle TG; Espiner EA; Frampton CM; Nicholls MG; Richards AM
Hypertension; 2000 Oct; 36(4):523-30. PubMed ID: 11040230
[TBL] [Abstract][Full Text] [Related]
15. (Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats.
Muller DN; Klanke B; Feldt S; Cordasic N; Hartner A; Schmieder RE; Luft FC; Hilgers KF
Hypertension; 2008 Mar; 51(3):676-81. PubMed ID: 18212268
[TBL] [Abstract][Full Text] [Related]
16. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
17. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
[TBL] [Abstract][Full Text] [Related]
18. Interactions of enhanced urocortin 2 and mineralocorticoid receptor antagonism in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2013 Jul; 6(4):825-32. PubMed ID: 23753530
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic, hormonal, and renal actions of adrenomedullin-2 in normal conscious sheep.
Charles CJ; Rademaker MT; Richards AM
Endocrinology; 2006 Apr; 147(4):1871-7. PubMed ID: 16410298
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor antagonism in ovine heart failure: acute hemodynamic, hormonal, and renal effects.
Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H
Am J Physiol; 1992 Jul; 263(1 Pt 2):H250-6. PubMed ID: 1636762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
